セルトリズマブペゴルの世界市場 2020年

• 英文タイトル：Global Certolizumab pegol Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113841 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、セルトリズマブペゴルの世界市場を調査対象にし、セルトリズマブペゴルの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（単回投与バイアル、単回投与プレフィルドシリンジ）、用途別分析（クローン病、活動性関節リウマチ、活動性乾癬性関節炎）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：UCB ・企業別売上、市場シェア ・セルトリズマブペゴルの地域別市場分析 ・セルトリズマブペゴルの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・セルトリズマブペゴルのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・セルトリズマブペゴルのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・セルトリズマブペゴルの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・セルトリズマブペゴルの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・セルトリズマブペゴルの種類別市場規模2015-2020：単回投与バイアル、単回投与プレフィルドシリンジ ・セルトリズマブペゴルの用途別市場規模2015-2020：クローン病、活動性関節リウマチ、活動性乾癬性関節炎 ・セルトリズマブペゴルの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Certolizumab pegol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Certolizumab pegol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Certolizumab pegol market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Certolizumab pegol market has been segmented into:
Single-dose vial
Single-dose prefilled syringe

By Application, Certolizumab pegol has been segmented into:
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Certolizumab pegol market presented in the report. This section sheds light on the sales growth of different regional and country-level Certolizumab pegol markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Certolizumab pegol market.

The report offers in-depth assessment of the growth and other aspects of the Certolizumab pegol market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Certolizumab pegol Market Share Analysis
Certolizumab pegol competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Certolizumab pegol sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Certolizumab pegol sales, revenue and market share for each player covered in this report.

The major players covered in Certolizumab pegol are:
UCB

レポート目次

---

1 Certolizumab pegol Market Overview
1.1 Product Overview and Scope of Certolizumab pegol
1.2 Classification of Certolizumab pegol by Type
1.2.1 Global Certolizumab pegol Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Certolizumab pegol Revenue Market Share by Type in 2019
1.2.3 Single-dose vial
1.2.4 Single-dose prefilled syringe
1.3 Global Certolizumab pegol Market by Application
1.3.1 Overview: Global Certolizumab pegol Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Crohn’s disease
1.3.3 Active rheumatoid arthritis
1.3.4 Active psoriatic arthritis
1.4 Global Certolizumab pegol Market by Regions
1.4.1 Global Certolizumab pegol Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Certolizumab pegol (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Certolizumab pegol Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Certolizumab pegol Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Certolizumab pegol Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Certolizumab pegol Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Certolizumab pegol Status and Prospect (2015-2025)
2 Company Profiles
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 UCB SWOT Analysis
2.1.4 UCB Product and Services
2.1.5 UCB Certolizumab pegol Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Certolizumab pegol Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Certolizumab pegol Players Market Share
3.2.2 Top 10 Certolizumab pegol Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Certolizumab pegol Revenue and Market Share by Regions
4.2 North America Certolizumab pegol Revenue and Growth Rate (2015-2020)
4.3 Europe Certolizumab pegol Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Certolizumab pegol Revenue and Growth Rate (2015-2020)
4.5 South America Certolizumab pegol Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Certolizumab pegol Revenue and Growth Rate (2015-2020)
5 North America Certolizumab pegol Revenue by Countries
5.1 North America Certolizumab pegol Revenue by Countries (2015-2020)
5.2 USA Certolizumab pegol Revenue and Growth Rate (2015-2020)
5.3 Canada Certolizumab pegol Revenue and Growth Rate (2015-2020)
5.4 Mexico Certolizumab pegol Revenue and Growth Rate (2015-2020)
6 Europe Certolizumab pegol Revenue by Countries
6.1 Europe Certolizumab pegol Revenue by Countries (2015-2020)
6.2 Germany Certolizumab pegol Revenue and Growth Rate (2015-2020)
6.3 UK Certolizumab pegol Revenue and Growth Rate (2015-2020)
6.4 France Certolizumab pegol Revenue and Growth Rate (2015-2020)
6.5 Russia Certolizumab pegol Revenue and Growth Rate (2015-2020)
6.6 Italy Certolizumab pegol Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Certolizumab pegol Revenue by Countries
7.1 Asia-Pacific Certolizumab pegol Revenue by Countries (2015-2020)
7.2 China Certolizumab pegol Revenue and Growth Rate (2015-2020)
7.3 Japan Certolizumab pegol Revenue and Growth Rate (2015-2020)
7.4 Korea Certolizumab pegol Revenue and Growth Rate (2015-2020)
7.5 India Certolizumab pegol Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Certolizumab pegol Revenue and Growth Rate (2015-2020)
8 South America Certolizumab pegol Revenue by Countries
8.1 South America Certolizumab pegol Revenue by Countries (2015-2020)
8.2 Brazil Certolizumab pegol Revenue and Growth Rate (2015-2020)
8.3 Argentina Certolizumab pegol Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Certolizumab pegol by Countries
9.1 Middle East & Africa Certolizumab pegol Revenue by Countries (2015-2020)
9.2 Saudi Arabia Certolizumab pegol Revenue and Growth Rate (2015-2020)
9.3 UAE Certolizumab pegol Revenue and Growth Rate (2015-2020)
9.4 Egypt Certolizumab pegol Revenue and Growth Rate (2015-2020)
9.5 South Africa Certolizumab pegol Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Certolizumab pegol Revenue and Market Share by Type (2015-2020)
10.2 Global Certolizumab pegol Market Forecast by Type (2019-2024)
10.3 Single-dose vial Revenue Growth Rate (2015-2025)
10.4 Single-dose prefilled syringe Revenue Growth Rate (2015-2025)
11 Global Certolizumab pegol Market Segment by Application
11.1 Global Certolizumab pegol Revenue Market Share by Application (2015-2020)
11.2 Certolizumab pegol Market Forecast by Application (2019-2024)
11.3 Crohn’s disease Revenue Growth (2015-2020)
11.4 Active rheumatoid arthritis Revenue Growth (2015-2020)
11.5 Active psoriatic arthritis Revenue Growth (2015-2020)
12 Global Certolizumab pegol Market Size Forecast (2021-2025)
12.1 Global Certolizumab pegol Market Size Forecast (2021-2025)
12.2 Global Certolizumab pegol Market Forecast by Regions (2021-2025)
12.3 North America Certolizumab pegol Revenue Market Forecast (2021-2025)
12.4 Europe Certolizumab pegol Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Certolizumab pegol Revenue Market Forecast (2021-2025)
12.6 South America Certolizumab pegol Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Certolizumab pegol Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Certolizumab pegol Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Certolizumab pegol by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Certolizumab pegol Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Certolizumab pegol Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. UCB Corporate Information, Location and Competitors
Table 6. UCB Certolizumab pegol Major Business
Table 7. UCB Certolizumab pegol Total Revenue (USD Million) (2017-2018)
Table 8. UCB SWOT Analysis
Table 9. UCB Certolizumab pegol Product and Solutions
Table 10. UCB Certolizumab pegol Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Certolizumab pegol Revenue (Million USD) by Players (2015-2020)
Table 12. Global Certolizumab pegol Revenue Share by Players (2015-2020)
Table 13. Global Certolizumab pegol Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Certolizumab pegol Revenue Market Share by Regions (2015-2020)
Table 15. North America Certolizumab pegol Revenue by Countries (2015-2020)
Table 16. North America Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Table 17. Europe Certolizumab pegol Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Certolizumab pegol Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Certolizumab pegol Revenue by Countries (2015-2020)
Table 20. South America Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Certolizumab pegol Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Table 23. Global Certolizumab pegol Revenue (Million USD) by Type (2015-2020)
Table 24. Global Certolizumab pegol Revenue Share by Type (2015-2020)
Table 25. Global Certolizumab pegol Revenue Forecast by Type (2021-2025)
Table 26. Global Certolizumab pegol Revenue by Application (2015-2020)
Table 27. Global Certolizumab pegol Revenue Share by Application (2015-2020)
Table 28. Global Certolizumab pegol Revenue Forecast by Application (2021-2025)
Table 29. Global Certolizumab pegol Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Certolizumab pegol Picture
Figure 2. Global Certolizumab pegol Revenue Market Share by Type in 2019
Figure 3. Single-dose vial Picture
Figure 4. Single-dose prefilled syringe Picture
Figure 5. Certolizumab pegol Revenue Market Share by Application in 2019
Figure 6. Crohn’s disease Picture
Figure 7. Active rheumatoid arthritis Picture
Figure 8. Active psoriatic arthritis Picture
Figure 9. Global Certolizumab pegol Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Certolizumab pegol Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Certolizumab pegol Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Certolizumab pegol Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Certolizumab pegol Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Certolizumab pegol Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Certolizumab pegol Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Certolizumab pegol Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Certolizumab pegol Revenue Market Share in 2019
Figure 18. Global Top 10 Players Certolizumab pegol Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Certolizumab pegol Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Certolizumab pegol Revenue Market Share by Regions (2015-2020)
Figure 22. Global Certolizumab pegol Revenue Market Share by Regions in 2018
Figure 23. North America Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 24. Europe Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 26. South America Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 28. North America Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Figure 29. North America Certolizumab pegol Revenue Market Share by Countries in 2019
Figure 30. USA Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 31. Canada Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 33. Europe Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Certolizumab pegol Revenue Market Share by Countries in 2019
Figure 35. Germany Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 36. UK Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 37. France Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 38. Russia Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 39. Italy Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Certolizumab pegol Revenue Market Share by Countries in 2019
Figure 42. China Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 43. Japan Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 44. Korea Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 45. India Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 47. South America Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Figure 48. South America Certolizumab pegol Revenue Market Share by Countries in 2019
Figure 49. Brazil Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Certolizumab pegol Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Certolizumab pegol Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 54. UAE Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Certolizumab pegol Revenue and Growth Rate (2015-2020)
Figure 57. Global Certolizumab pegol Revenue Share by Type (2015-2020)
Figure 58. Global Certolizumab pegol Revenue Share by Type in 2019
Figure 59. Global Certolizumab pegol Market Share Forecast by Type (2021-2025)
Figure 60. Global Single-dose vial Revenue Growth Rate (2015-2020)
Figure 61. Global Single-dose prefilled syringe Revenue Growth Rate (2015-2020)
Figure 62. Global Certolizumab pegol Revenue Share by Application (2015-2020)
Figure 63. Global Certolizumab pegol Revenue Share by Application in 2019
Figure 64. Global Certolizumab pegol Market Share Forecast by Application (2021-2025)
Figure 65. Global Crohn’s disease Revenue Growth Rate (2015-2020)
Figure 66. Global Active rheumatoid arthritis Revenue Growth Rate (2015-2020)
Figure 67. Global Active psoriatic arthritis Revenue Growth Rate (2015-2020)
Figure 68. Global Certolizumab pegol Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Certolizumab pegol Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Certolizumab pegol Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Certolizumab pegol Revenue Market Forecast (2021-2025)
Figure 72. Europe Certolizumab pegol Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Certolizumab pegol Revenue Market Forecast (2021-2025)
Figure 74. South America Certolizumab pegol Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Certolizumab pegol Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---